Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Disruption of nicotine conditioning by dopamine D3 receptor ligands

Abstract

Tobacco smoking is the first cause of preventable death in modern countries. Nicotine replacement therapy or sustained release bupropion helps smoking cessation, but relapse rates are still very high. Nicotine, like other drugs of abuse, activates the dopamine mesolimbic system, which originates in the ventral tegmental area and projects notably to the nucleus accumbens. Situations or environmental stimuli previously associated with cigarette smoking, for example, smell of cigarette smoke, can elicit craving in abstinent smokers and promote relapse. Reducing the effects of nicotine-associated cues might therefore have potential therapeutic utility for smoking cessation. Such an approach has been validated for cocaine in animals, by using the dopamine D3 receptor-selective partial agonist BP 897, which inhibits cocaine cue-induced drug-seeking behavior. Here we show that rats repeatedly injected with nicotine in a particular environment develop nicotine-conditioned locomotor responses, accompanied by an increase in D3 receptor expression in the nucleus accumbens. This conditioned behavior was inhibited by BP 897 or a selective D3 receptor antagonist, suggesting that antagonizing dopamine selectively at the D3 receptor disrupts nicotine-conditioned effects and might represent a novel therapeutic approach for smoking cessation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999; 400: 371–375.

    Article  CAS  Google Scholar 

  2. Goldberg SR, Morse WH, Goldberg DM . Behavior maintained under a second-order schedule by intramuscular injection of morphine or cocaine in rhesus monkeys. J Pharmacol Exp Ther 1976; 199: 278–286.

    CAS  PubMed  Google Scholar 

  3. Arroyo M, Markou A, Robbins TW, Everitt BJ . Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology 1999; 140: 331–344.

    Article  Google Scholar 

  4. Beardsley PM, Sokoloff P, Balster RL, Schwartz J-C . The D3R partial agonist BP 897 attenuates the discriminative stimulus effects of cocaine and amphetamine and is not self-administered. Behav Pharmacol 2001; 11: 1–11.

    Article  Google Scholar 

  5. Pert A, Post R, Weiss SR . Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr 1990; 97: 208–241.

    CAS  PubMed  Google Scholar 

  6. Walter S, Kuschinsky K . Conditioning of nicotine effects on motility and behaviour in rats. Naunyn-Schmiedeberg Arch Pharmacol 1989; 339: 208–213.

    CAS  Google Scholar 

  7. Robinson TE, Berridge KC . Incentive-sensitization and addiction. Addiction 2001; 96: 103–114.

    Article  CAS  Google Scholar 

  8. Post RM, Weiss SR, Pert A . The role of context and conditioning in behavioral sensitization to cocaine. Psychopharmacol Bull 1987; 23: 425–429.

    CAS  PubMed  Google Scholar 

  9. Kalivas PW, Stewart J . Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16: 223–244.

    Article  CAS  Google Scholar 

  10. Birrell CE, Balfour DJ . The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine. Psychopharmacology (Berl) 1998; 140: 142–149.

    Article  CAS  Google Scholar 

  11. Cadoni C, Di Chiara G . Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol 2000; 387: R23–R25.

    Article  CAS  Google Scholar 

  12. Imperato A, Mulas A, Di Chiara G . Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986; 132: 337–338.

    Article  CAS  Google Scholar 

  13. Lévesque D, Martres M-P, Diaz J, Griffon N, Lammers CH, Sokoloff P et al. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA 1995; 92: 1719–1723.

    Article  Google Scholar 

  14. Pontieri FE, Tanda G, Orzi F, Di Chiara G . Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255–257.

    Article  CAS  Google Scholar 

  15. Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG et al. Characterization of 125I R trans 7-OH-PIPAT binding to dopamine D3 receptors in rat olfactory tubercule. J Pharmacol Exp Ther 1994; 268: 935–942.

    CAS  PubMed  Google Scholar 

  16. Staley JK, Mash DC . Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996; 16: 6100–6106.

    Article  CAS  Google Scholar 

  17. Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz J-C . Induction of dopamine D3 receptor as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997; 94: 3363–3367.

    Article  CAS  Google Scholar 

  18. Pilla M, Hutcheson DM, Adib-Samil P, Potton E, Everitt BJ . Seeking responses for cocaine, heroin and natural reinforcers are differentially modulated by dopamine D3 receptors. Soc Neurosci Abst 2001; 27: Program No 647.16.

  19. Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY et al. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 2000; 294: 1154–1165.

    CAS  Google Scholar 

  20. Di Ciano P, Underwood R, Hagan JJ, Everitt BJ . Attenuation of cue-controlled drug-seeking by a selective D3 dopamine receptor antagonist. Behav Pharmacol 2001; 12 (Suppl 1): S29.

    Google Scholar 

  21. Mirenowicz J, Schultz W . Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996; 379: 449–451.

    Article  CAS  Google Scholar 

  22. Ridray S, Griffon N, Souil E, Mignon V, Carboni S, Diaz J et al. Coexpression of dopamine D1 and D3 receptors in rat ventral striatum: opposite and synergistic functional interactions. Eur J Neurosci 1998; 10: 1676–1686.

    Article  CAS  Google Scholar 

  23. Bevins RA, Besheer J, Pickett KS . Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol Biochem Behav 2001; 68: 135–145.

    Article  CAS  Google Scholar 

  24. Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel FA . Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH 39166 in acutely ill schizophrenic patients. Psychopharmacology (Berl) 1995; 121: 309–316.

    Article  CAS  Google Scholar 

  25. Eke T, Talbot JF, Lawden MC . Severe persistent visual field constriction associated with vigabatrin. B Med J 1997; 314: 180–181.

    Article  CAS  Google Scholar 

  26. Shiffman S, Shumaker SA, Abrams DB, Cohen S, Garvey A, Grunberg NE et al. Models of smoking relapse. Health Psychol 1986; 5: 13–27.

    Article  Google Scholar 

  27. Le Foll B, Schwartz J-C, Sokoloff P . Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 2000; 15: 140–146.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants to PS from the European Commission (FP5 Programme QLG4-CT-1999-00075) and to BLF from the Mission Interministérielle de Lutte contre la Dépendance et la Toxicomanie (RBM 01-02).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Sokoloff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Le Foll, B., Schwartz, JC. & Sokoloff, P. Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 8, 225–230 (2003). https://doi.org/10.1038/sj.mp.4001202

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001202

This article is cited by

Search

Quick links